Clinical Trials

Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

8th February 2018

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in a phase 1 study...

Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant – an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine.

by Content Team

8th February 2018

Allergan plc , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two...

Guidelines extended to improve the use of feedback from patients in clinical trials.

by Content Team

8th February 2018

Researchers recommend changes to international guidelines used in the development of clinical trials in an effort to obtain useful information...

Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium

by Content Team

18th January 2018

MacroGenics, Inc. a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer,...

Medivir completes pre-clinical safety studies with MIV-818 to treat hepatocellular carcinoma

by Content Team

8th January 2018

Medivir AB, a research-based pharmaceutical company, announced the successful completion of the pre-clinical safety studies for MIV-818 to enable the...

Akcea begins phase 2b study of AKCEA-APOCIII-LRx in patients with hypertriglyceridemia & established CVD

by Content Team

8th January 2018

Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious...

Avelas completes patient enrollment in phase 2 study of AVB-620 in women with primary, nonrecurrent breast cancer undergoing surgery

by Content Team

8th January 2018

Avelas Biosciences, a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and...

RDD Pharma completes enrollment in European phase 3 trial of RDD-1219 to treat chronic anal fissure

by Content Team

6th January 2018

RDD Pharma, a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for anorectal diseases and gastrointestinal...

MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis

by Content Team

5th January 2018

MiMedx Group, Inc. the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with...